Welcome to BioLegend’s one-of-a-kind advanced search. Search by any one of the single fields below or narrow down your searches by using multiple parameters. Looking for an anti-mouse NK cell antibody for IHC? Or looking for a FITC-conjugated antibody against a human marker for dendritic cells to use for flow cytometry? Only BioLegend’s advanced search can provide you with the best answers. If you have further questions, please contact our technical service team at 858-768-5801.
Use this document lookup tool to find Current Product Datasheets, Certificates of Analysis, or MSDS for any antibody products you have purchased from BioLegend.
Use the search box below to perform a site search of BioLegend.com powered by Google™.
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.
Concentration:
0.2 mg/ml
Storage & Handling:
The antibody solution should be stored undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
COA:
Application References:
1. Kataoka H, et al. 1997. Develop. Growth Diff. 39:729
CD309, also known as vascular endothelial growth factor receptor 2, VEGFR2, fetal liver kinase-1. CD309 is a member of the tyrosine protein kinase family that contains a single pass transmembrane receptor with a protein kinase domain and seven immunoglobulin-like domains in the extracellular region. FLK-1 is expressed at high levels in adult heart, lung, kidney, brain, and skeletal muscle. FLK-1 is a receptor for vascular endothelial growth factor (VEGF) or VEGFC. It plays an important role in the development of vascular endothelial, hematopoietic cells, and vascular permeability. Avas 12 recognizes different epitope from clone 89B3A5.
*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/terms). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.
This data display is provided for general comparisons between formats. Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors. If you need assistance with selecting the best format contact our expert technical support team.
Purified anti-mouse CD309 (VEGFR2, Flk-1)
Endothelial bEnd.3 cells stained with Avas 12 PE
PE anti-mouse CD309 (VEGFR2, Flk-1)
Endothelial bEnd.3 cells stained with Avas 12 PE
APC anti-mouse CD309 (VEGFR2, Flk-1)
bEnd.3 endothelial cells stained with Avas12a1 APC
Alexa Fluor® 488 anti-mouse CD309 (VEGFR2, Flk-1)
bEnd.3 endothelial cells stained with Avas12a1 Alexa Fluor® 488
Biotin anti-mouse CD309 (VEGFR2, Flk-1)
bEnd.3 mouse endothelial cells stained with biotinylated Avas12, followed by Sav-PE
PerCP/Cy5.5 anti-mouse CD309 (VEGFR2, Flk-1)
bEnd.3 mouse endothelial cells stained with Avas12 PerCP/Cy5.5
